Cong Y, Abulimiti M, Matsumoto Y, Jin J
Front Oncol. 2024; 14:1507157.
PMID: 39726703
PMC: 11669655.
DOI: 10.3389/fonc.2024.1507157.
Sun Y, Li Y, Zhou W, Liu Z
BMC Oral Health. 2024; 24(1):406.
PMID: 38556858
PMC: 10981818.
DOI: 10.1186/s12903-024-04182-0.
Ren D, Zhuang X, Lv Y, Zhang Y, Xu J, Gao F
Iran J Public Health. 2023; 52(10):2117-2127.
PMID: 37899918
PMC: 10612548.
DOI: 10.18502/ijph.v52i10.13850.
Chakraborty N, Holmes-Hampton G, Gautam A, Kumar R, Hritzo B, Legesse B
Sci Rep. 2023; 13(1):18496.
PMID: 37898651
PMC: 10613244.
DOI: 10.1038/s41598-023-45250-9.
Chen H, Hu K, Xie Y, Qi Y, Li W, He Y
Int J Mol Sci. 2022; 23(13).
PMID: 35806389
PMC: 9266818.
DOI: 10.3390/ijms23137385.
Carboranes as unique pharmacophores in antitumor medicinal chemistry.
Chen Y, Du F, Tang L, Xu J, Zhao Y, Wu X
Mol Ther Oncolytics. 2022; 24:400-416.
PMID: 35141397
PMC: 8807988.
DOI: 10.1016/j.omto.2022.01.005.
AKIP1 promotes tumor progression by cancer-related pathways and predicts prognosis in tongue squamous cell carcinoma.
Wang N, Bai D, Kristiansen E, Deng R, Zhang S
Am J Transl Res. 2021; 13(11):12338-12351.
PMID: 34956456
PMC: 8661143.
Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis.
Camuzi D, de Almeida Simao T, Dias F, Pinto L, Soares-Lima S
Cancers (Basel). 2021; 13(22).
PMID: 34830785
PMC: 8616074.
DOI: 10.3390/cancers13225630.
miR‑383 increases the cisplatin sensitivity of lung adenocarcinoma cells through inhibition of the RBM24‑mediated NF‑κB signaling pathway.
He B, Wu C, Sun W, Qiu Y, Li J, Liu Z
Int J Oncol. 2021; 59(5).
PMID: 34558639
PMC: 8460061.
DOI: 10.3892/ijo.2021.5267.
Early Diagnosis of Oral Squamous Cell Carcinoma (OSCC) by miR-138 and miR-424-5p Expression as a Cancer Marker.
Bolandparva F, Hashemi Nasab M, Mohamadnia A, Garajei A, Farhadi Nasab A, Bahrami N
Asian Pac J Cancer Prev. 2021; 22(7):2185-2189.
PMID: 34319042
PMC: 8607090.
DOI: 10.31557/APJCP.2021.22.7.2185.
Correlation of carbonic anhydrase 9 (CA9) with pathological T-stage and prognosis in patients with oral tongue squamous cell carcinoma.
Wang S, Fu Z, Wang Y, Sun Y, Cui L, Wang C
Ann Transl Med. 2020; 8(22):1521.
PMID: 33313266
PMC: 7729320.
DOI: 10.21037/atm-20-7144.
MicroRNA's - The vibrant performers in the oral cancer scenario.
Solomon M, Radhakrishnan R
Jpn Dent Sci Rev. 2020; 56(1):85-89.
PMID: 32612717
PMC: 7310692.
DOI: 10.1016/j.jdsr.2020.04.001.
Circular RNA_0001742 has potential to predict advanced tumor stage and poor survival profiles in tongue squamous cell carcinoma management.
Yao Y, Bi L, Zhang C
J Clin Lab Anal. 2020; 34(8):e23330.
PMID: 32463532
PMC: 7439411.
DOI: 10.1002/jcla.23330.
Polish Propolis-Chemical Composition and Biological Effects in Tongue Cancer Cells and Macrophages.
Wezgowiec J, Wieczynska A, Wieckiewicz W, Kulbacka J, Saczko J, Pachura N
Molecules. 2020; 25(10).
PMID: 32455950
PMC: 7287845.
DOI: 10.3390/molecules25102426.
MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1.
Wei Z, Chang K, Fan C, Zhang Y
Cancer Cell Int. 2020; 20:82.
PMID: 32190006
PMC: 7071636.
DOI: 10.1186/s12935-020-1166-6.
SNHG17 enhances the malignant characteristics of tongue squamous cell carcinoma by acting as a competing endogenous RNA on microRNA-876 and thereby increasing specificity protein 1 expression.
Liu X, Zhang B, Jia Y, Fu M
Cell Cycle. 2020; 19(6):711-725.
PMID: 32089063
PMC: 7145335.
DOI: 10.1080/15384101.2020.1727399.
circRNA circ-CCND1 promotes the proliferation of laryngeal squamous cell carcinoma through elevating CCND1 expression via interacting with HuR and miR-646.
Zang Y, Li J, Wan B, Tai Y
J Cell Mol Med. 2020; 24(4):2423-2433.
PMID: 31951319
PMC: 7028846.
DOI: 10.1111/jcmm.14925.
miRNA-101 Targets TGF-βR1 to Retard the Progression of Oral Squamous Cell Carcinoma.
Wang Y, Jia R, Diao S, He J, Jia L
Oncol Res. 2019; 28(2):203-212.
PMID: 31831099
PMC: 7851522.
DOI: 10.3727/096504019X15761480623959.
microRNA-493 inhibits tongue squamous cell carcinoma oncogenicity via directly targeting HMGA2.
Jiao D, Liu Y, Tian Z
Onco Targets Ther. 2019; 12:6947-6959.
PMID: 31695410
PMC: 6717877.
DOI: 10.2147/OTT.S210567.
Analysis of Treg/Th17 cells in patients with tongue squamous cell carcinoma.
Liu C, Tong Z, Tan J, Xin Z
Exp Ther Med. 2019; 18(3):2187-2193.
PMID: 31452709
PMC: 6704530.
DOI: 10.3892/etm.2019.7814.